Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Healthcare Biotechnology
Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Agree or Don’t Agree!
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(286)
•••
Post by beenthereon Jan 29, 2022 7:55pm
275 Views
Post# 34375366

Agree or Don’t Agree!

Agree or Don’t Agree!

Agree or  don't agree!

Pro JD or Anti JD!

Been here for 8 years + or for a week!

What  I want to know is over all this time I have  had to put up with  JD telling me how I ( and others) am destroying his ( your) investment!

I mean this has went on for years!  And if all the regulars don't agree with me than you are lying to yourselves!

I didn't agree with JD! My thoughts were if people listen to what is being said on a BB than they deserve what they get!

To me fine to read a BB but do your own DD and make up your own mind. After all it IS your money if you want toi invest!

Sorry I digress!

To all  who is reading this I ask ...who is the one destroying your investment  today?  ..and all this week?

Mr Negative himself! Mr JD! And what makes it so much worse is his opinion is respected here!

JD has pretty much destroyed any goodwill he has done in the past!

Talk about destroying bridges!! 

I think I would have waited for the cheque to clear!! lol



 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities